Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis
2007
Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment
2010
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
2010
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer
2004
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Stem Cell Transplantation for Indolent Lymphoma and Chronic Lymphocytic Leukemia
2010
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
2010
The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
2012
Hemolytic disease due to membrane ion channel disorders
2004
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Hereditary stomatocytosis and cation leaky red cells — Recent developments
2009
Tumor immunoediting and immunosculpting pathways to cancer progression
2007
Genomic and epigenomic co-evolution in follicular lymphomas
2014
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
2003
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
2010
Impaired PIEZO1 function in patients with a novel autosomal recessive congenital lymphatic dysplasia
2015 StandoutNobel
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples
2009
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels
2013 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
2006
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
2005
An Extreme Consequence of Splenectomy in Dehydrated Hereditary Stomatocytosis: Gradual Thrombo‐embolic Pulmonary Hypertension and Lung–Heart Transplantation
2003
Detection of minimal residual disease
2001
Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction
2007
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
2001
Risk factors for chronic thromboembolic pulmonary hypertension
2008
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
2005
miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death
2012
Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr
2004
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
2002
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Red Cell Membrane Disorders
2005
Recurrent B-cell Neoplasms After Rituximab Therapy: An Immunophenotypic and Genotypic Study
2002
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
2006
Neutrophils, from Marrow to Microbes
2010 Standout
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
2008
Stress-induced immune dysfunction: implications for health
2005 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency
2001
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
2004
Risk Factors for Chronic Thromboembolic Pulmonary Hypertension
2006
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort
2010
Refinement of the hereditary xerocytosis locus on chromosome 16q in a large Canadian kindred
2011
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Splenectomy and chronic thromboembolic pulmonary hypertension
2005
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Maladie thromboembolique récidivante après splénectomie pour stomatocytose héréditaire
2007
Conditional MLL‐CBP targets GMP and models therapy‐related myeloproliferative disease
2005
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
2004
Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
2003
Cancer as an evolutionary and ecological process
2006 Standout
Realistic Pathologic Classification of Acute Myeloid Leukemias
2001
Lyme borreliosis
2011 Standout
No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome
2011 StandoutNobel
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Chronic thromboembolic pulmonary hypertension
2014
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Mild dehydrated hereditary stomatocytosis revealed by marked hepatosiderosis
2006
Genomewide Search for Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis): Mapping of Locus to Chromosome 16 (16q23-qter)
1998
The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations
2004
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24.
2000
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Pulmonary Hypertension after Splenectomy?
1999
Acute Myeloid Leukemia
2015 Standout
Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients
2003
Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
2010
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The structure of the ankyrin-binding site of β-spectrin reveals how tandem spectrin-repeats generate unique ligand-binding properties
2009 StandoutNobel
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
2009
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system
2009
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
2009
A genetic syndrome associating dehydrated hereditary stomatocytosis, pseudohyperkalaemia and perinatal oedema
1998
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Disorders of erythrocyte volume homeostasis
2015
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
2005
Genome-Wide Single Nucleotide Polymorphism Analysis Reveals Frequent Partial Uniparental Disomy Due to Somatic Recombination in Acute Myeloid Leukemias
2005
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Transformed follicular non-Hodgkin lymphoma
2014
The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells
2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
2003
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline
2010
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
2008
Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations
2010
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of John Amess being referenced
Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
2007
Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis
2001
Genome‐wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation‐mediated fusion events
2003
THROMBO‐EMBOLIC DISEASE AFTER SPLENECTOMY FOR HEREDITARY STOMATOCYTOSIS
1996
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2
2003
Long‐term outcome of patients surviving for more than ten years following treatment for acute leukaemia
2001
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti‐CD20): a retrospective cohort analysis
2001
Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After High-Dose Therapy With Autologous Hematopoietic Progenitor-Cell Support for Lymphoid Malignancies
2000
High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up
2000
Detection of Chromosome Abnormalities Pre–High-Dose Treatment in Patients Developing Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After Treatment for Non-Hodgkin’s Lymphoma
2001